Today's Topline - 4/24/20
Friday, April 24, 2020
Source: MedTech Association
Good Friday morning:
While it seems obvious that the use of evidence-based research to inform our public health decisions is the sine qua non of good science, the pressing desire to move beyond the COVID-19 pandemic has led some to abandon this well-settled approach. In their commentary, Why Georgia Isn’t Ready to Reopen, in Charts, authors Nathaniel Lash and Gus Wezerek analyze Georgia’s infection rates, testing and underlying health risks and argue that it’s singularly unwise for the state to reopen. As they point out, reopening the state at this point risks a spike in infections just as the virus could be peaking.
At the same time, the Washington Post reports that after a presentation Thursday that touched on the disinfectants that can kill the coronavirus on surfaces and in the air, the president pondered whether those chemicals could be used to fight the virus inside the human body. “I see the disinfectant that knocks it out in a minute, one minute,” President Trump said during Thursday’s coronavirus press briefing. “And is there a way we can do something like that by injection inside, or almost a cleaning?” The question spurred doctors to respond with warnings against injecting or otherwise ingesting disinfectants, which are highly toxic.
Recognizing the importance of current, comprehensive information to guide healthcare decisions and practices, MedTech member Hillrom is partnering with AgileMD to offer COVID-19 clinical pathways at no charge for 12 months. AgileMD provides an EHR-integrated software platform that embeds instant access to advanced clinical pathways and predictive analytics into physician and nursing workflows. With clinical recommendations changing daily and staff turning over quickly due to exposure and illness, these clinical pathways can empower providers in the ED, inpatient and outpatient settings to quickly implement best practices for evidence-based, consistent care. We applaud Hillrom for making this important information widely available.
MedTech exists to deliver value to the bio/med industry and serve those on the front lines of healthcare advances. We rely on our members to make that possible. Please take a moment to join or renew your membership today. Renewing members can lock in last year’s rate through 2021. New members who join today will receive 3 free months on their membership year. Don’t wait. We need your support to continue the work we do.